Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Marinus Pharmaceuticals, Inc. (MRNS)

LOS ANGELES, June 24, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 5, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ: MRNS) securities between March 17, 2021 and May 7, 2024, inclusive (the "Class Period"). On April 15, 2024, Marinus disclosed that its Phase 3 RAISE trial for the treatment of refractory ...